BACKGROUND: We sought to identify optimal approaches by calibrating longitudinal cognitive performance across studies with different neuropsychological batteries. METHODS: We examined four approaches to calibrate cognitive performance in nine longitudinal studies of Alzheimer's disease (AD) (n = 10,875): (1) common test, (2) standardize and average available tests, (3) confirmatory factor analysis (CFA) with continuous indicators, and (4) CFA with categorical indicators. To compare precision, we determined the minimum sample sizes needed to detect 25% cognitive decline with 80% power. To compare criterion validity, we correlated cognitive change from each approach with 6-year changes in average cortical thickness and hippocampal volume using available MRI data from the AD Neuroimaging Initiative. RESULTS: CFA with categorical indicators required the smallest sample size to detect 25% cognitive decline with 80% power (n = 232) compared to common test (n = 277), standardize-and-average (n = 291), and CFA with continuous indicators (n = 315) approaches. Associations with changes in biomarkers changes were the strongest for CFA with categorical indicators. CONCLUSIONS: CFA with categorical indicators demonstrated greater power to detect change and superior criterion validity compared to other approaches. It has wide applicability to directly compare cognitive performance across studies, making it a good way to obtain operational phenotypes for genetic analyses of cognitive decline among people with AD.
BACKGROUND: We sought to identify optimal approaches by calibrating longitudinal cognitive performance across studies with different neuropsychological batteries. METHODS: We examined four approaches to calibrate cognitive performance in nine longitudinal studies of Alzheimer's disease (AD) (n = 10,875): (1) common test, (2) standardize and average available tests, (3) confirmatory factor analysis (CFA) with continuous indicators, and (4) CFA with categorical indicators. To compare precision, we determined the minimum sample sizes needed to detect 25% cognitive decline with 80% power. To compare criterion validity, we correlated cognitive change from each approach with 6-year changes in average cortical thickness and hippocampal volume using available MRI data from the AD Neuroimaging Initiative. RESULTS: CFA with categorical indicators required the smallest sample size to detect 25% cognitive decline with 80% power (n = 232) compared to common test (n = 277), standardize-and-average (n = 291), and CFA with continuous indicators (n = 315) approaches. Associations with changes in biomarkers changes were the strongest for CFA with categorical indicators. CONCLUSIONS: CFA with categorical indicators demonstrated greater power to detect change and superior criterion validity compared to other approaches. It has wide applicability to directly compare cognitive performance across studies, making it a good way to obtain operational phenotypes for genetic analyses of cognitive decline among people with AD.
Authors: Teri A Manolio; Laura Lyman Rodriguez; Lisa Brooks; Gonçalo Abecasis; Dennis Ballinger; Mark Daly; Peter Donnelly; Stephen V Faraone; Kelly Frazer; Stacey Gabriel; Pablo Gejman; Alan Guttmacher; Emily L Harris; Thomas Insel; John R Kelsoe; Eric Lander; Norma McCowin; Matthew D Mailman; Elizabeth Nabel; James Ostell; Elizabeth Pugh; Stephen Sherry; Patrick F Sullivan; John F Thompson; James Warram; David Wholley; Patrice M Milos; Francis S Collins Journal: Nat Genet Date: 2007-09 Impact factor: 38.330
Authors: Deborah E Barnes; Irena S Cenzer; Kristine Yaffe; Christine S Ritchie; Sei J Lee Journal: Alzheimers Dement Date: 2014-02-01 Impact factor: 21.566
Authors: Vivek Prabhakaran; Veena A Nair; Benjamin P Austin; Christian La; Thomas A Gallagher; Yijing Wu; Donald G McLaren; Guofan Xu; Patrick Turski; Howard Rowley Journal: Neuroimaging Clin N Am Date: 2012-05 Impact factor: 2.264
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2013-08-07 Impact factor: 21.566
Authors: Bruce M Psaty; Christopher J O'Donnell; Vilmundur Gudnason; Kathryn L Lunetta; Aaron R Folsom; Jerome I Rotter; André G Uitterlinden; Tamara B Harris; Jacqueline C M Witteman; Eric Boerwinkle Journal: Circ Cardiovasc Genet Date: 2009-02
Authors: Rachel F Buckley; Elizabeth C Mormino; Rebecca E Amariglio; Michael J Properzi; Jennifer S Rabin; Yen Ying Lim; Kathryn V Papp; Heidi I L Jacobs; Samantha Burnham; Bernard J Hanseeuw; Vincent Doré; Annette Dobson; Colin L Masters; Michael Waller; Christopher C Rowe; Paul Maruff; Michael C Donohue; Dorene M Rentz; Dylan Kirn; Trey Hedden; Jasmeer Chhatwal; Aaron P Schultz; Keith A Johnson; Victor L Villemagne; Reisa A Sperling Journal: Alzheimers Dement Date: 2018-05-24 Impact factor: 21.566
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2017-03-22 Impact factor: 21.566
Authors: Sharon K Inouye; Edward R Marcantonio; Cyrus M Kosar; Douglas Tommet; Eva M Schmitt; Thomas G Travison; Jane S Saczynski; Long H Ngo; David C Alsop; Richard N Jones Journal: Alzheimers Dement Date: 2016-04-18 Impact factor: 21.566
Authors: Stefan Walter; Carole Dufouil; Alden L Gross; Richard N Jones; Dan Mungas; Teresa J Filshtein; Jennifer J Manly; Thalida E Arpawong; M Maria Glymour Journal: Alzheimer Dis Assoc Disord Date: 2019 Jul-Sep Impact factor: 2.703
Authors: Guusje van der Leeuw; Laura H P Eggermont; Ling Shi; William P Milberg; Alden L Gross; Jeffrey M Hausdorff; Jonathan F Bean; Suzanne G Leveille Journal: J Gerontol A Biol Sci Med Sci Date: 2015-10-03 Impact factor: 6.053
Authors: Anja Soldan; Corinne Pettigrew; Anne M Fagan; Suzanne E Schindler; Abhay Moghekar; Christopher Fowler; Qiao-Xin Li; Steven J Collins; Cynthia Carlsson; Sanjay Asthana; Colin L Masters; Sterling Johnson; John C Morris; Marilyn Albert; Alden L Gross Journal: Neurology Date: 2019-03-06 Impact factor: 9.910
Authors: Casey M Rebholz; Morgan E Grams; Yuan Chen; Alden L Gross; Yingying Sang; Josef Coresh; Elizabeth Selvin Journal: Am J Epidemiol Date: 2017-10-15 Impact factor: 4.897
Authors: Mark A Espeland; Jiu-Chiuan Chen; Julie Weitlauf; Kathleen M Hayden; Stephen R Rapp; Susan M Resnick; Lorena Garcia; Brad Cannell; Laura D Baker; Bonnie C Sachs; Hilary A Tindle; Robert Wallace; Ramon Casanova Journal: J Am Geriatr Soc Date: 2018-07-04 Impact factor: 5.562